Remission Phase in Paediatric Type 1 Diabetes: New Understanding and Emerging Biomarkers.

Abstract

Type 1 diabetes (T1D) is a metabolic disease of unknown aetiology that results from the autoimmune destruction of the β-cells. Clinical onset with classic hyperglycaemic symptoms occurs much more frequently in children and young adults, when less than 30% of β-cells remain. Exogenous insulin administration is the only treatment for patients. However, due to… (More)
DOI: 10.1159/000479030

2 Figures and Tables

Topics

  • Presentations referencing similar topics